ZNF449 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.177200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.876820E-01
Normal-vs-Stage2
3.399400E-03
Normal-vs-Stage3
2.673600E-02
Normal-vs-Stage4
1.626650E-01
Stage1-vs-Stage2
2.488600E-01
Stage1-vs-Stage3
1.577430E-01
Stage1-vs-Stage4
9.582400E-01
Stage2-vs-Stage3
3.649800E-01
Stage2-vs-Stage4
3.739000E-01
Stage3-vs-Stage4
6.394200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.244600E-03
Normal-vs-AfricanAmerican
2.986000E-02
Normal-vs-Asian
7.262500E-03
Caucasian-vs-AfricanAmerican
5.523200E-01
Caucasian-vs-Asian
2.033400E-01
AfricanAmerican-vs-Asian
7.477200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.259770E-03
Normal-vs-Female
1.205970E-02
Male-vs-Female
1.783580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.465000E-01
Normal-vs-Age(41-60Yrs)
1.756210E-02
Normal-vs-Age(61-80Yrs)
1.501360E-03
Normal-vs-Age(81-100Yrs)
9.355100E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.915000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.766000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.297600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.648300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.807900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.591200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.440700E-04
Normal-vs-Daily Drinker
4.278800E-03
Normal-vs-Weekly Drinker
2.496400E-02
Normal-vs-Occasional Drinker
1.940590E-03
Normal-vs-Social Drinker
1.262380E-01
Non Drinker-vs-Daily Drinker
7.481800E-01
Non Drinker-vs-Weekly Drinker
4.829800E-01
Non Drinker-vs-Occasional Drinker
5.681800E-01
Non Drinker-vs-Social Drinker
1.123190E-01
Daily Drinker-vs-Weekly Drinker
4.209800E-01
Daily Drinker-vs-Occasional Drinker
4.539800E-01
Daily Drinker-vs-Social Drinker
7.639800E-02
Weekly Drinker-vs-Occasional Drinker
8.204000E-01
Weekly Drinker-vs-Social Drinker
3.644800E-01
Occasional Drinker-vs-Social Drinker
2.173600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.700000E-02
Normal-vs-Grade 2
7.959500E-03
Normal-vs-Grade 3
2.353700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.947200E-01
Grade 1-vs-Grade 3
8.926000E-01
Grade 1-vs-Grade 4
8.700000E-02
Grade 2-vs-Grade 3
7.017000E-01
Grade 2-vs-Grade 4
7.959500E-03
Grade 3-vs-Grade 4
2.353700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.818400E-04
Normal-vs-NonDiabetic
3.817600E-03
Diabetic-vs-NonDiabetic
2.665400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.354820E-01
Normal-vs-NoPancreatitis
2.519700E-03
Pancreatitis-vs-NoPancreatitis
3.687200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.422300E-03
Normal-vs-N1
2.823500E-03
N0-vs-N1
8.741400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.245600E-01
Normal-vs-TP53-NonMutant
5.529600E-02
TP53-Mutant-vs-TP53-NonMutant
3.269800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
